Pfizer Inc.

About Pfizer Inc.

Pfizer is one of the world's premier biopharmaceutical companies, committed to finding innovative cures and advancing cancer care. With a history dating back to 1849, Pfizer focuses on enriching and extending life through revolutionary medicines and has a strong dedication to research and development.

Products & Services

General Products:Pfizer develops a wide range of pharmaceutical products, each resulting from extensive research involving over 1,500 scientists, 500,000 lab tests, and 36 clinical trials before the first prescription.

Pfizer RxPathways:A program that connects eligible patients to assistance programs offering insurance support, co-pay help, and medicines for free or at a savings.

Specialties

Internal Medicine Inflammation & Immunology Vaccines Oncology Clinical Trials Cancer Care

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 31000000000 MR: - FA: 31,000,000,000 FAN: 31000000000	D: 2023-05-16 FD: 2023-05-16	4 investors

Debt Latest

2023-05-16

$31.0B

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

O

Olivier Dirat

Associate Research Fellow and Group Leader, Chemical Development Active Pharmaceutical Ingredients

J

Jeff Settleman

Chief Scientific Officer for Oncology Research and Development

K

Kendra K. Bence

Executive Director, Metabolism

LinkedIn (Pro only)

J

Jeremy D Gale

Vice President and Clinical Portfolio Leader

A

Alejandra Gurtman

Senior Vice President, Head Vaccine Clinical Research and Development

N

Nicholas Kitchin

VP, Vaccine Clinical Research & Development

View 57 more team members with Pro

Unlock Full Team Directory

Recent News

Pfizer Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised